The paper prescription pad. It’s traditional. It’s recognizable. And it’s going the way of the dinosaur. eRx has been in place for a while now, making those little pads of paper a thing of the past until it’s time to prescribe a controlled substance. But no more.
Electronic Prescribing of Controlled Substances (EPCS) is permissible across the United States. We are proud to say that this convenient service is available through MicroMD. MicroMD EPCS Gold assists prescribers in saying “Goodbye” to their prescription pad by reducing their reliance on paper-based prescriptions. This solution is built into MicroMD’s normal eRx workflow, featuring DrFirst’s EPCS Gold DEA-certified framework, as well as Surescripts eRx transmission on the backend.
This powerful combination, integrated directly into the MicroMD eRx workflow, features its own DEA certification so that prescribers can rest assured that they are meeting both Federal and varying state requirements for EPCS while not having to leave the software to prescribe controlled substances. This is especially important for providers in New York who are required to electronically prescribe controlled substances beginning March 27, 2016.
It’s time to embrace the efficiency, safety, and environmental friendliness of EPCS. For more information click here.